🇺🇸 In open-label phase: treatment with tofacitinib in United States

In open-label phase: treatment with tofacitinib (in-open-label-phase-treatment-with-tofacitinib) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

In open-label phase: treatment with tofacitinib in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is In open-label phase: treatment with tofacitinib approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for In open-label phase: treatment with tofacitinib in United States?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.